This is a snippet of the transcript, sign up to read more.
I don't know how it is now, but back then, medical would support or suggest if we found something. But BD did most of the new client effort and they were pretty good. Once the client was engaged and came to Cincinnati or for a high priority, when we put our team A, depending on the priority they had, ABC, our success rate was very high. It was 75% and up. Remember, the clients always call about three CROs, so your success is probably going to be one-third. But ours was more than two-thirds. So they had very good results. When the client showed up at the Cincinnati office and they looked at everything, they would be extremely pleased. Most of the time, we would get the business.
This is a snippet of the transcript, sign up to read more.
Yes, I think there are a couple of things to highlight, all of which you mentioned, but specifically, one point is that they show data of previous clients who have returned for services in the relevant therapeutic area. For example, if you're looking into a neurology bid defense, they might show that in the last five years, they had 12 clients, conducted 12 phase two trials, three of which were unsuccessful, while nine succeeded. Out of these, seven or maybe nine returned for phase three. They present this data very transparently, and such numbers are quite impressive. When the retention rate is that high, it instills a lot of confidence in new clients that this company is repeatedly chosen, indicating they must be doing something right.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research